The Food and Drug Administration (FDA) inspected ImpactLife in Macomb on April 20, reviewing its handling of blood and blood products, the agency confirmed on its website.
The final assessment found no need for ImpactLife to alter any operational management procedures.
Around the country, the FDA regularly inspects organizations to ensure both workplaces and their products comply with federal health and safety laws. Summaries of inspection findings are made available to the public.
The FDA states on its website that it oversees the approval and quality of human and animal drugs, biologics, medical devices and tobacco goods to protect public health.
Information for this article is sourced from the U.S. Food and Drug Administration. Complete details are available here.
